CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction" Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction Dapagliflozin for treating chronic heart failure with reduced ejection fraction Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure The Management of Atrial Fibrillation in Heart Failure: An Expert Panel Consensus Association of Reduced Apical Untwisting With Incident HF in Asymptomatic Patients With HF Risk Factors Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators - The RAID Trial INTERMACS Profiles and Outcomes Among Non–Inotrope-Dependent Outpatients With Heart Failure and Reduced Ejection Fraction

Expert Opinion2020 Oct 14;41(39):3769-3773.

JOURNAL:Eur Heart J. Article Link

The multiple causes and treatments of heart failure: focus on genetic and molecular mechanisms and non-pharmacological interventions

F Crea. Keywords: HF; non-pharmacological interventions; mechanisms

Full Text PDF